Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9257901 | 0.89 | PTGS2 (0.46) | ALOX5TSHRLMNAPTGS2 | |
| SCHEMBL28776369 | 0.83 | PTGS2 (0.39) | CYP1A2ALOX5CYP2D6TSHRLMNA | |
| SCHEMBL4484070 | 0.82 | CYP1A2 (0.52) | CYP1A2ALOX5CYP2D6TSHRSMN1; SMN2 | |
| SCHEMBL5444246 | 0.80 | ESR1 (0.52) | CYP1A2ALOX5CYP2D6SMN1; SMN2LMNA | |
| SCHEMBL2415101 | 0.80 | ALOX5 (0.46) | ALOX5SMN1; SMN2ALDH1A1LMNAPTGS2 | |
| SCHEMBL8956391 | 0.80 | PTGS2 (0.61) | CYP1A2ALOX5TSHRALDH1A1LMNA | |
| SCHEMBL621292 | 0.80 | BRD4 (0.50) | SMN1; SMN2POLBALDH1A1PTGS2CES2 | |
| SCHEMBL421564 | 0.80 | PTGS2 (0.61) | CYP1A2ALOX5TSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL5149430 | 0.80 | PTGS2 (0.61) | CYP1A2ALOX5TSHRSMN1; SMN2ALDH1A1 | |
| SCHEMBL12280124 | 0.80 | CYP1A2 (0.55) | CYP1A2ALOX5CYP2D6TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2358688-B1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS INC (US) | 2014-03-12 | — | — | EP | disclosed |
| US-8440707-B2 | Antagonists of lysophosphatidic acid receptors | AMIRA PHARMACEUTICALS, INC. (US) | 2013-05-14 | — | — | US | disclosed |
| US-20110301142-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. | 2011-12-08 | — | — | US | disclosed |
| US-20110301211-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. | 2011-12-08 | — | — | US | disclosed |
| US-20110301142-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. | 2011-12-08 | — | — | US | disclosed |
| US-20110301142-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. | 2011-12-08 | — | — | US | disclosed |
| US-8048902-B2 | Antagonists of lysophosphatidic acid receptors | AMIRA PHARMACEUTICALS, INC. (US) | 2011-11-01 | — | — | US | disclosed |
| EP-2358688-A2 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | Amira Pharmaceuticals, Inc. (US) | 2011-08-24 | — | — | EP | disclosed |
| US-20110196005-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC., (US) | 2011-08-11 | — | — | US | disclosed |
| WO-2010077882-A2 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010077882-A2 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| WO-2010077883-A2 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2010-07-08 | — | — | WO | disclosed |
| US-20100152257-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | AMIRA PHARMACEUTICALS, INC. (US) | 2010-06-17 | — | — | US | disclosed |
| CN-1078586-C | Phenylalkanamide derivatives and agrohor-ticultural bactericides | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2002-01-30 | — | — | CN | disclosed |
| US-6075055-A | EXCELLENT FUNGICIDAL ACTIVITIES WITH REGARD TO RICE BLAST AND THE LIKE, WHILE AT THE SAME TIME DO NOT HINDER DESIRABLE PLANT GROWTH | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2000-06-13 | — | — | US | disclosed |
| EP-0854134-B1 | PHENYLALKANAMIDE DERIVATIVES AND AGROHORTICULTURAL BACTERICIDES | KUMAII CHEMICAL INDUSTRY CO LT (JP) | 2000-04-26 | — | — | EP | disclosed |
| CN-1192728-A | Phenylalkanamide derivatives and agricultural or horticultural fungicides | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1998-09-09 | — | — | CN | disclosed |
| EP-0854134-A1 | PHENYLALKANAMIDE DERIVATIVES AND AGROHORTICULTURAL BACTERICIDES | KumaiI Chemical Industry Co., Ltd. (JP) | 1998-07-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152257-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | LPAR1, LPAR2, LPAR4 | CYP1A2 4427/4885ALOX5 206/4885CYP2D6 4651/4885 |
| US-20110196005-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | LPAR1, LPAR2, LPAR4 | CYP1A2 4427/4885ALOX5 206/4885CYP2D6 4651/4885 |
| US-20110301211-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | LPAR1, LPAR2, LPAR4 | CYP1A2 4427/4885ALOX5 206/4885CYP2D6 4651/4885 |
| US-20110301142-A1 | ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS | LPAR1, LPAR2, LPAR4 | CYP1A2 4427/4885ALOX5 206/4885CYP2D6 4651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.